Marcel Bekkenk

View Scopus Profile

Research activity per year

If you made any changes in Pure these will be visible here soon.

30 Article
6 Letter
5 Review article
1 Chapter

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
the T2B! immunity against SARS-CoV-2 study group, 1 Feb 2023, In: Journal of Autoimmunity. 135, 102984.
Research output: Contribution to journal › Article › Academic › peer-review
A cohort analysis of surgically treated primary head and neck lentigo maligna (melanoma): Prognostic value of melanoma subtype and new insights in the clinical value of guideline adherence
Elshot, Y. S., Zupan-Kajcovski, B., Ouwerkerk, W., Klop, W. M. C., Lohuis, P. J. F. M., Bol, M., Crijns, M. B., Bekkenk, M. W., de Rie, M. A. & Balm, A. J. M., 2022, (E-pub ahead of print) In: European Journal of Surgical Oncology.
Research output: Contribution to journal › Article › Academic › peer-review
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Stalman, E. W., Wieske, L., van Dam, K. P. J., Kummer, L. Y., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G. J., van der Kooi, A. J., Raaphorst, J., Löwenberg, M., Takkenberg, R. B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., & 39 othersHilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A. E., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, O. Y. K., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D. J., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Steenhuis, M., Keijzer, S., Keijser, J. B. D., Boogaard, A., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., Rispens, T., van Ham, S. M., Kuijpers, T. W. & Eftimov, F., 5 Sep 2022, In: Annals of the Rheumatic Diseases. 81, 12, p. 1757-1766 10 p., 222904.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
T2B! immunity against SARS-CoV-2 study group, 1 Jun 2022, In: The Lancet Rheumatology. 4, 6, p. e417-e429
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
T2B! immunity against SARS-CoV-2 study group, May 2022, In: The Lancet Rheumatology. 4, 5, p. e338-e350
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Marcel Bekkenk

Network

Dive into details

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

A cohort analysis of surgically treated primary head and neck lentigo maligna (melanoma): Prognostic value of melanoma subtype and new insights in the clinical value of guideline adherence

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

Marcel Bekkenk

Network

Research output

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

A cohort analysis of surgically treated primary head and neck lentigo maligna (melanoma): Prognostic value of melanoma subtype and new insights in the clinical value of guideline adherence

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study